{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T18:52:16Z","timestamp":1720983136153},"reference-count":36,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.ygyno.2015.06.039","type":"journal-article","created":{"date-parts":[[2015,7,5]],"date-time":"2015-07-05T08:11:03Z","timestamp":1436083863000},"page":"676-682","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["HPV16 RNA patterns defined by novel high-throughput RT-qPCR as triage marker in HPV-based cervical cancer precursor screening"],"prefix":"10.1016","volume":"138","author":[{"given":"Daniela","family":"H\u00f6fler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerd","family":"B\u00f6hmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reinhard","family":"von Wasielewski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heinrich","family":"Neumann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gordana","family":"Halec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dana","family":"Holzinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bolormaa","family":"Dondog","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lutz","family":"Gissmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Pawlita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2015.06.039_bb0005","author":"IARC"},{"key":"10.1016\/j.ygyno.2015.06.039_bb0010","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/pgp.0b013e31805152ab","article-title":"CIN2 is a much less reproducible and less valid diagnosis than CIN3: results from a histological review of population-based cervical samples","volume":"26","author":"Carreon","year":"2007","journal-title":"Int. J. Gynecol. Pathol."},{"key":"10.1016\/j.ygyno.2015.06.039_bb0015","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1001\/jama.285.11.1500","article-title":"Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study","volume":"285","author":"Stoler","year":"2001","journal-title":"JAMA"},{"issue":"Suppl. 3:S3","key":"10.1016\/j.ygyno.2015.06.039_bb0020","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.vaccine.2006.06.018","article-title":"Chapter 5: updating the natural history of HPV and anogenital cancer","volume":"24","author":"Moscicki","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.ygyno.2015.06.039_bb0025","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/1097-0215(20001120)89:6<529::AID-IJC11>3.0.CO;2-G","article-title":"Screening for high-grade cervical intra-epithelial neoplasia and cancer by testing for high-risk HPV, routine cytology or colposcopy","volume":"89","author":"Schneider","year":"2000","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2015.06.039_bb0030","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/GRF.0b013e3182836b6a","article-title":"2012 cervical cancer screening guidelines and the future role of HPV testing","volume":"56","author":"Priebe","year":"2013","journal-title":"Clin. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2015.06.039_bb0035","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1002\/ijc.25211","article-title":"The health and economic effects of HPV DNA screening in The Netherlands","volume":"127","author":"Berkhof","year":"2010","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2015.06.039_bb0040","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/GCO.0b013e32835c5d10","article-title":"Primary human papillomavirus testing in organized cervical screening","volume":"25","author":"Dillner","year":"2013","journal-title":"Curr. Opin. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2015.06.039_bb0045","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/S0140-6736(07)61450-0","article-title":"Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial","volume":"370","author":"Bulkmans","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2015.06.039_bb0050","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/S1470-2045(09)70296-7","article-title":"Trials comparing cytology with human papillomavirus screening","volume":"10","author":"Arbyn","year":"2009","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ygyno.2015.06.039_bb0055","doi-asserted-by":"crossref","first-page":"c1804","DOI":"10.1136\/bmj.c1804","article-title":"Rate of cervical cancer, severe intraepithelial neoplasia, and adenocarcinoma in situ in primary HPV DNA screening with cytology triage: randomised study within organised screening programme","volume":"340","author":"Anttila","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.ygyno.2015.06.039_bb0060","doi-asserted-by":"crossref","first-page":"S230","DOI":"10.1016\/j.ygyno.2007.07.021","article-title":"The new technologies for cervical cancer screening randomised controlled trial. An overview of results during the first phase of recruitment","volume":"107","author":"Ronco","year":"2007","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2015.06.039_bb0065","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1002\/ijc.27650","article-title":"EUROGIN 2011 roadmap on prevention and treatment of HPV-related disease","volume":"131","author":"Arbyn","year":"2012","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2015.06.039_bb0070","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.ygyno.2012.11.030","article-title":"Implementing specificity of HPV-DNA primary screening in a successful organised cervical cancer prevention programme","volume":"128","author":"Zappacosta","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2015.06.039_bb0075","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1056\/NEJMp020178","article-title":"Adding a test for human papillomavirus DNA to cervical-cancer screening","volume":"348","author":"Wright","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2015.06.039_bb0080","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1158\/0008-5472.CAN-09-2514","article-title":"Diagnosing cervical cancer and high-grade precursors by HPV16 transcription patterns","volume":"70","author":"Schmitt","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.ygyno.2015.06.039_bb0085","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.mcp.2011.05.003","article-title":"The HPV16 transcriptome in cervical lesions of different grades","volume":"25","author":"Schmitt","year":"2011","journal-title":"Mol. Cell. Probes"},{"key":"10.1016\/j.ygyno.2015.06.039_bb0090","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.mcp.2011.03.003","article-title":"The HPV transcriptome in HPV16 positive cell lines","volume":"25","author":"Schmitt","year":"2011","journal-title":"Mol. Cell. Probes"},{"key":"10.1016\/j.ygyno.2015.06.039_bb0095","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/ijc.27605","article-title":"Biological activity of probable\/possible high-risk human papillomavirus types in cervical cancer","volume":"132","author":"Halec","year":"2012","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2015.06.039_bb0100","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1158\/1055-9965.EPI-07-2796","article-title":"Human papillomavirus infection in Ulaanbaatar, Mongolia: a population-based study","volume":"17","author":"Dondog","year":"2008","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.ygyno.2015.06.039_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1158\/0008-5472.CAN-11-3934","article-title":"Viral RNA patterns and high viral load reliably define oropharynx carcinomas with active HPV16 involvement","volume":"72","author":"Holzinger","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.ygyno.2015.06.039_bb0110","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1128\/JCM.02227-07","article-title":"Homogeneous amplification of genital human alpha papillomaviruses by PCR using novel broad-spectrum GP5+ and GP6+ primers","volume":"46","author":"Schmitt","year":"2008","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.ygyno.2015.06.039_bb0115","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1158\/1055-9965.EPI-12-1067","article-title":"Viral load of high-risk human papillomaviruses as reliable clinical predictor for the presence of cervical lesions","volume":"22","author":"Schmitt","year":"2013","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.ygyno.2015.06.039_bb0120","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/ijc.27675","article-title":"High-throughput SNP-based authentication of human cell lines","volume":"132","author":"Castro","year":"2012","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2015.06.039_bb0125","doi-asserted-by":"crossref","first-page":"e119","DOI":"10.1093\/nar\/gkp581","article-title":"High-throughput detection and multiplex identification of cell contaminations","volume":"37","author":"Schmitt","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ygyno.2015.06.039_bb0130","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.1073\/pnas.80.12.3812","article-title":"A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions","volume":"80","author":"Durst","year":"1983","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ygyno.2015.06.039_bb0135","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1046\/j.1365-2303.1998.00155.x","article-title":"A case\u2013control study of true-positive versus false-negative cervical smears in women with cervical intraepithelial neoplasia (CIN) III","volume":"9","author":"O'Sullivan","year":"1998","journal-title":"Cytopathology"},{"key":"10.1016\/j.ygyno.2015.06.039_bb0140","doi-asserted-by":"crossref","first-page":"E946","DOI":"10.1002\/ijc.27532","article-title":"Molecular mapping of high-grade cervical intraepithelial neoplasia shows etiological dominance of HPV16","volume":"131","author":"van der Marel","year":"2012","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2015.06.039_bb0145","doi-asserted-by":"crossref","first-page":"e24451","DOI":"10.1371\/journal.pone.0024451","article-title":"Differential methylation of the HPV 16 upstream regulatory region during epithelial differentiation and neoplastic transformation","volume":"6","author":"Vinokurova","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ygyno.2015.06.039_bb0150","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1158\/1055-9965.EPI-12-0905","article-title":"Human papillomavirus DNA methylation as a potential biomarker for cervical cancer","volume":"21","author":"Clarke","year":"2012","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.ygyno.2015.06.039_bb0155","first-page":"213","article-title":"Promoter methylation of candidate genes associated with familial testicular cancer","volume":"3","author":"Mirabello","year":"2012","journal-title":"Int. J. Mol. Epidemiol. Genet."},{"key":"10.1016\/j.ygyno.2015.06.039_bb0160","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1002\/ijc.26326","article-title":"A four-gene methylation marker panel as triage test in high-risk human papillomavirus positive patients","volume":"130","author":"Eijsink","year":"2012","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2015.06.039_bb0165","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1158\/1078-0432.CCR-10-2548","article-title":"Combined promoter methylation analysis of CADM1 and MAL: an objective triage tool for high-risk human papillomavirus DNA-positive women","volume":"17","author":"Hesselink","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ygyno.2015.06.039_bb0170","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1158\/1940-6207.CAPR-14-0237","article-title":"Methylation analysis of the FAM19A4 gene in cervical scrapes is highly efficient in detecting cervical carcinomas and advanced CIN2\/3 lesions","volume":"7","author":"De Strooper","year":"2014","journal-title":"Cancer Prev. Res."},{"key":"10.1016\/j.ygyno.2015.06.039_bb0175","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1002\/ijc.28138","article-title":"CADM1 and MAL promoter methylation levels in hrHPV-positive cervical scrapes increase proportional to degree and duration of underlying cervical disease","volume":"133","author":"Bierkens","year":"2013","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2015.06.039_bb0180","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1002\/ijc.27750","article-title":"Elevated methylation of HPV16 DNA is associated with the development of high grade cervical intraepithelial neoplasia","volume":"132","author":"Mirabello","year":"2013","journal-title":"Int. J. Cancer"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825815300603?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825815300603?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,21]],"date-time":"2018-09-21T04:24:23Z","timestamp":1537503863000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825815300603"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S0090825815300603"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2015.06.039","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HPV16 RNA patterns defined by novel high-throughput RT-qPCR as triage marker in HPV-based cervical cancer precursor screening","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2015.06.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}